ArticleFrontiers in psychiatry2022

Editorial: Precision medicine approaches for heterogeneous conditions such as autism spectrum disorders (The need for a biomarker exploration phase in clinical trials - Phase 2m).

David Q Beversdorf et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.